evidencegaps
Primary study · included by 1 review

Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study.

Guo 2024 · Guo Yiyu, Xu Xinyu, Wang Tian, et al. · International immunopharmacology · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Guo 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.